Evidence map›Paper›PMID 23791479›Full record

ArticleCytokine2013

Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis.

Daryn R Michael, Tim G Ashlin, Charlotte S Davies, Hayley Gallagher, Thomas W Stoneman, Melanie L Buckley, Dipak P Ramji

Open access · hybridAbstract read
In one paragraph

Article in Cytokine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cell-Penetrating Peptides Delivering siRNAs: An Overview.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  9. Role of Macrophages and RhoA Pathway in Atherosclerosis.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis.Biochimica et biophysica acta. Molecular basis of disease · 2019
    Article
  13. Article
  14. The pervasiveness of macropinocytosis in oncological malignancies.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Daryn R MichaelCardiff School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, United Kingdom. Electronic address: darynmichael@hotmail.com.
Tim G Ashlin
Charlotte S Davies
Hayley Gallagher
Thomas W Stoneman
Melanie L Buckley
Dipak P Ramji
Cardiff University · GB

Funding

British Heart Foundation PG/08/073/25520
6 · The paper itself

Abstract

A key event during the formation of lipid-rich foam cells during the progression of atherosclerosis is the uptake of modified low-density lipoproteins (LDL) by macrophages in response to atherogenic mediators in the arterial intima. In addition to scavenger receptor-dependent uptake of LDL, macropinocytosis is known to facilitate the uptake of LDL through the constitutive and passive internalization of large quantities of extracellular solute. In this study we confirm the ability of macropinocytosis to facilitate the uptake of modified LDL by human macrophages and show its modulation by TGF-β, IFN-γ, IL-17A and IL-33. Furthermore we show that the TGF-β-mediated inhibition of macropinocytosis is a Smad-2/-3-independent process.

Indexed as

AtherosclerosisBiological TransportCell DifferentiationCells, CulturedCytochalasin DFoam CellsGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)HumansInflammationInterferon-gammaInterleukin-17Interleukin-33InterleukinsLipoproteins, LDLMacrophagesNucleic Acid Synthesis InhibitorsCytochalasin DGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)IL17A protein, humanIL33 protein, humanInterferon-gammaInterleukin-17Interleukin-33InterleukinsLipoproteins, LDLNucleic Acid Synthesis InhibitorsRNA, Small InterferingSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTransforming Growth Factor beta1,1-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyane perchlorateacetylated LDLAcLDLApoapolipoproteinAtherosclerosisBMDMbone marrow-derived macrophageCD-36cluster of differentiation 36CytokineDiIFoam cellGAPDHglyceraldehyde 3-phosphate dehydrogenaseHMDMhuman acute monocytic leukemia cellshuman monocyte-derived macrophagesIFN-γILinterferon-γinterleukinLDLLow density lipoproteinlow-density lipoproteinslucifer yellowLYMacropinocytosisoxidized LDLOxLDLscavenger receptor Ashort hairpin RNAshRNASR-ATGF-βTHP-1transforming growth factor-β

Identifiers

PMID23791479
PMCPMC3779350
OpenAlexW2021966427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.